KDT-3594

DRUG4 trials

Sponsors

Kissei Pharmaceutical Co., Ltd.

Conditions

Parkinson Disease

Phase 1

Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's Disease

CompletedNCT03068481

Kissei Pharmaceutical Co., Ltd.Parkinson Disease

Start: 2017-02-20End: 2018-08-13Updated: 2019-04-01

Phase 2

A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.

CompletedNCT03845387

Kissei Pharmaceutical Co., Ltd.Parkinson Disease

Start: 2019-02-26End: 2020-02-21Updated: 2021-02-17

A Clinical Study of KDT-3594 in Japanese Patients With Early Parkinson's Disease

CompletedNCT04867551

Kissei Pharmaceutical Co., Ltd.Parkinson Disease

Start: 2021-05-15End: 2021-09-06Updated: 2022-05-11

A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's Disease

CompletedNCT06722729

Kissei Pharmaceutical Co., Ltd.Parkinson Disease

Start: 2024-12-16End: 2026-01-14Updated: 2026-09-10